Editorial: Birthing the genetics of peripartum cardiomyopathy

Circulation

Volumn 121, Issue 20, 2010, Pages 2157-2159

  Anderson, Jeffrey L ^a   Horne, Benjamin D ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT;

CARDIOMYOPATHY; CLINICAL FEATURE; CONGESTIVE CARDIOMYOPATHY; EDITORIAL; GENE MUTATION; GENETIC ANALYSIS; GENETIC ASSOCIATION; HEART FAILURE; HEART LEFT VENTRICLE HYPERTROPHY; HEART VENTRICLE EJECTION; HUMAN; MORBIDITY; MORTALITY; PATHOGENESIS; PERIPARTUM CARDIOMYOPATHY; PREGNANCY; PRIORITY JOURNAL; RISK FACTOR; FEMALE; GENETIC PREDISPOSITION; GENETICS; MUTATION; NOTE; PREGNANCY COMPLICATION; PUERPERAL DISORDER;

CARDIOMYOPATHIES; CARDIOMYOPATHY, DILATED; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MUTATION; PREGNANCY; PREGNANCY COMPLICATIONS; PUERPERAL DISORDERS;

EID: 77953023402     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.110.956169     Document Type: Editorial

References (23)

1. Sliwa K, Fett J, Elkayam U. Peripartum cardiomyopathy. Lancet. 2006; 368:687-693.
2. Elkayam U, Akhter MW, Singh H, Khan S, Bitar F, Hameed A, Shotan A. Pregnancy-associated cardiomyopathy. Circulation. 2005;111: 2050-2055.
3. Bales AC, Lang RM. Peripartum cardiomyopathy [CD-ROM]. UpToDate. Version 10.1. Waltham, MA: Wolters Kluwer Health; 2002.
4. Richie C. Clinical contributions to the pathology, diagnosis, and treatment of certain chronic diseases of the heart. Edinb Med Surg J. 1849;2:333.
5. Hull E, Hafkesbring E. "Toxic" postpartal heart disease. New Orleans Med Surg J. 1937;89:550.
6. Demakis JG, Rahimtoola SH. Peripartum cardiomyopathy. Circulation. 1971;44:964-968.
7. Hibbard JU, Lindheimer M, Lang RM. A modified definition of peri-partum cardiomyopathy and prognosis based on echocardiography. Obstet Gynecol. 1999;94:311-316.
8. Mielniczuk LM, Williams K, Davis DR, Tang AS, Lemery R, Green MS, Gollob MH, Haddad H, Birnie DH. Frequency of peripartum cardiomy-opathy. Am J Cardiol. 2006;97:1765-1768.
9. Goland S, Modi K, Bitar F, Janmohamed M, Mirocha JM, Czer LS, Illum S, Hatamizadeh P, Eldayam U. Clinical profile and predictors of complications in peripartum cardiomyopathy. J Card Fail. 2006;15:645-650.
10. Amos AM, Jaber WA, Russell SD. Improved outcomes in peripartum cardiomyopathy with contemporary (management). Am Heart J. 2006; 152:509-513.
11. Pearson GD, Veille JC, Rahimtoola SH, Hsia J, Oakley CM, Hosenpud JD, Ansari A, Baughman KL. Peripartum cardiomyopathy: National Heart, Lung and Blood Institute and Office of Rare Diseases (National Institutes of Health) workshop recommendations and review. JAMA. 2000;283:1183-1188.
12. Toescu F, Nuttall SL, Martin U, Kendall MJ, Dunne F. Oxidative stress and normal pregnancy. Clin Endocrinol. 2002;57:609-613.
13. Sliwa K, Baluwe L, Tibazarwa K, Libhaber E, Smedema J-P, Becker A, McMurray J, Yamac H, Labidi S, Struhman I, Hiliker-Kleiner D. Evaluation of bromocriptine in the treatment of acute severe peripartum cardiomyopathy. Circulation. 2010;121:1465-1473.
14. Elkayam U, Goland S. Bromocriptine for the treatment of peripartum cardiomyopathy. Circulation. 2010;121:1463-1464.
15. Pearl W. Familial occurrence of peripartum cardiomyopathy. Am Heart J. 1995;129:421-422.
16. van Spaendonck-Zwarts KY, van Tintelen JP, van Veldhuisen DJ, van der Werf R, Jongbloed JDH, Paulus WJ, Dooijes D, van den Berg MP. Peripartum cardiomyopathy as a part of familial dilated cardiomyopathy. Circulation. 2010;121:2169-2175.
17. Burkett EL, Hershberger RE. Clinical and genetic issues in familial dilated cardiomyopathy. J Am Coll Cardiol. 2005;45:969-981.
18. Morales A, Painter T, Li R, Siegfried JD, Li D, Norton N, Hershberger RE. Rare variant mutations in pregnancy-associated or peripartum car-diomyopathy. Circulation. 2010;121:2176-2182.
19. Morales A, Cowan J, Dagua J, Hershberger RE. Family history: an essential tool for cardiovascular genetic medicine. Congest Heart Fail. 2008;14:37-45.
20. van der Roest WP, Pennings JM, Bakker M, van den Berg MP, van Tintelen JP. Family letters are an effective way to inform relatives about inherited cardiac disease. Am J Med Genet. 2009;149A:357-363.
21. Horne BD, Anderson JL, Carlquist JF, Muhlestein JB, Renlund DG, Bair TL, Pearson RR, Camp NJ. Generating genetic risk scores from intermediate phenotypes for use in association studies of clinically significant endpoints. Ann Human Genetics. 2005;69:176-186.
22. Anderson JL, Carlquist JF, Horne BD, Hopkins PN. Progress in unraveling the genetics of coronary artery disease and myocardial infarction. Current Atherosclerosis Reports. 2007;9:179-186.
23. Horne BD, Kfoury AG, Rasmusson KD, Brunisholz KD, Zeigler AN, Connolly JJ, Porter TF, Fisher PW, Muhlestein JB, Carlquist JF, May HT, Anderson JL, Renlund DG. Identification of genome-wide single nucle-otide polymorphisms in peripartum cardiomyopathy. J Heart Lung Transplant. 2009;28:S181-S182.